J Electrodiagn Neuromuscul Dis.
2022 Aug;24(2):46-49. 10.18214/jend.2022.00024.
Hirayama Disease Diagnosed after COVID-19 mRNA Vaccination in an Adolescent Patient: A Case Report
- Affiliations
-
- 1Department of Physical Medicine and Rehabilitation, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea
- 2Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea
- 3Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea
- KMID: 2535383
- DOI: http://doi.org/10.18214/jend.2022.00024
Abstract
- Hirayama disease is characterized by initially progressive muscular weakness and wasting of the distal upper limbs in young people. It has a male predominance, and its progression spontaneously arrests within several years. Here, we report the case of a 15-year-old girl with findings of Hirayama disease on spinal magnetic resonance imaging (MRI) after she visited the hospital with unilateral muscle weakness that occurred after coronavirus disease 2019 mRNA vaccination. She was asymptomatic for 3 weeks after vaccination; however, starting the night before hospitalization, her right limb began to lose strength. MRI demonstrated typical Hirayama disease findings.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hypertensive crisis following mRNA COVID-19 vaccination in adolescents: two case reports
- Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
- Adult-onset Still’s Disease after BNT162b2 mRNA COVID-19 Vaccine
- Ipsilateral Radial Neuropathy after COVID-19 mRNA Vaccination in an Immunocompetent Young Man
- mRNA COVID-19 Vaccine-Associated Subserosal Eosinophilic Gastroenteritis: A Case Report
